drugset / Trial / NCT01523041

Comparison of Two Formulations of Biphasic Insulin Aspart 70

NCT01523041

Phase 1 Completed 24 enrolled Novo Nordisk A/S
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to compare two formulations of biphasic insulin aspart 70 and characterise the pharmacokinetics of biphasic insulin aspart 50 and biphasic insulin aspart 70 in healthy male subjects.

Timeline

Start
1999-11-03
Primary completion
1999-11-30
Completion
1999-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic Subcutaneous

Indications